NEOVACS: Update on the number of shares and voting rights

On May 16, 2025, Neovacs, a biopharmaceutical company based in Suresnes and listed on Euronext Growth Paris, published information regarding the composition of its share capital. As of April 30, 2025, the total number of shares and gross and net voting rights stands at 59,870,096.

The company also specifies the number of shares issued each month since the beginning of 2025. For example, in April, this number reached 55,038,017, including shares issued from OCEANE and ORA bonds.

It is recalled that this type of financial transaction, which can lead to a dilution of capital, requires increased vigilance on the part of investors due to the potential downward pressure on the share price.